<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>**Smoking and the risks of adult diseases** • tobalcepi</title>
<!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
<link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png">
<link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png">
<link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png">
<link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png">
<!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><!-- Bootstrap --><link href="https://cdnjs.cloudflare.com/ajax/libs/bootswatch/3.4.0/flatly/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous">
<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script><meta property="og:title" content="**Smoking and the risks of adult diseases**">
<meta property="og:description" content="tobalcepi">
<meta property="og:image" content="https://stapm.github.io/tobalcepi/logo.png">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--><!-- Global site tag (gtag.js) - Google Analytics --><script async src="https://www.googletagmanager.com/gtag/js?id=UA-167990045-1"></script><script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-167990045-1');
</script>
</head>
<body data-spy="scroll" data-target="#toc">
    

    <div class="container template-article">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">tobalcepi</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">1.6.1</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
<li>
  <a href="../articles/tobalcepi.html">Get started</a>
</li>
<li>
  <a href="../reference/index.html">Functions</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Technical documentation
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
<li>
      <a href="../articles/Methods_for_STAPM_disease_risks.html">Disease risk methods</a>
    </li>
    <li>
      <a href="../articles/Alcohol-attributable_diseases_and_dose-response_curves.html">Alcohol disease risks</a>
    </li>
    <li>
      <a href="../articles/Smoking_and_the_risks_of_adult_diseases.html">Tobacco disease risks</a>
    </li>
  </ul>
</li>
      </ul>
<ul class="nav navbar-nav navbar-right">
<li>
  <a href="https://github.com/STAPM/tobalcepi" class="external-link">
    <span class="fab fa-github fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="https://gitlab.com/stapm/r-packages/tobalcepi" class="external-link">
    <span class="fab fa-gitlab fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="https://stapm.gitlab.io/software.html" class="external-link">
    <span class="fa fa-code"></span>
     
  </a>
</li>
      </ul>
</div>
<!--/.nav-collapse -->
  </div>
<!--/.container -->
</div>
<!--/.navbar -->

      

      </header><script src="Smoking_and_the_risks_of_adult_diseases_files/kePrint-0.0.1/kePrint.js"></script><link href="Smoking_and_the_risks_of_adult_diseases_files/lightable-0.0.1/lightable.css" rel="stylesheet">
<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header toc-ignore">
      <h1 data-toc-skip><strong>Smoking and the risks of adult
diseases</strong></h1>
            
      
      
      <div class="hidden name"><code>Smoking_and_the_risks_of_adult_diseases.Rmd</code></div>

    </div>

    
    
<!-- Laura Webster^1^, Colin Angus^1^, Alan Brennan^1^, Duncan Gillespie^1^    -->
<!-- \vskip 1em -->
<!-- ^1^School of Health and Related Research (ScHARR), The University of Sheffield -->
<!-- \vskip 1em -->
<!-- **Address for correspondence**:\ -->
<!-- Dr Duncan Gillespie\ -->
<!-- Section of Health Economics and Decision Science,\ -->
<!-- School for Health and Related Research,\ -->
<!-- The University of Sheffield,\ -->
<!-- Regent Court, Regent Street, Sheffield, S1 4DA, UK\ -->
<!-- Email: [duncan.gillespie\@sheffield.ac.uk](mailto:duncan.gillespie@sheffield.ac.uk){.email} -->
<!-- \vskip 1em -->
<p>The code that accompanies this vignette can be found in the
<code>tobalcepi</code> R package <a href="https://stapm.github.io/tobalcepi/" class="uri">https://stapm.github.io/tobalcepi/</a> (Github code
repository <a href="https://github.com/STAPM/tobalcepi" class="external-link uri">https://github.com/STAPM/tobalcepi</a>).</p>
<p>This vignette is a reproduction of the content in: Webster, Laura;
Angus, Colin; Brennan, Alan; Gillespie, Duncan (2018): Smoking and the
risks of adult diseases. The University of Sheffield. <a href="https://doi.org/10.15131/shef.data.7411451.v1" class="external-link uri">https://doi.org/10.15131/shef.data.7411451.v1</a></p>
<p>Therefore the citation above should be used for this vignette. This
vignette differs from the report cited above in being produced by the
code within the tobalcepi R package. This vignette therefore presents
the risk functions and acts as a means to quality assure the code in the
tobalcepi R package.<br></p>
<div style="page-break-after: always;"></div>
<div class="section level2">
<h2 id="acknowledgements">Acknowledgements<a class="anchor" aria-label="anchor" href="#acknowledgements"></a>
</h2>
<p>The authors would like to thank John Britton of the University of
Nottingham and UK Centre for Tobacco and Alcohol Studies, Katrina Brown
of Cancer Research UK for their advice and input at various stages of
the preparation of this document.</p>
</div>
<div class="section level2">
<h2 id="introduction">Introduction<a class="anchor" aria-label="anchor" href="#introduction"></a>
</h2>
<p>This document presents our list of <strong>52</strong> adult diseases
related to smoking and the corresponding relative risks of disease due
to smoking, explaining our choices of disease definitions and risk
sources. Figure @ref(fig:smkrelrisks) shows the variation in
disease-specific risks. We focus on the risks of current smoking and
limit ourselves to diseases that affect the consumer themselves
e.g. excluding secondary effects of smoking on children. We assume the
equivalence of relative risks and odds ratios. Our starting point was
the Royal College of Physician’s (RCP) report “Hiding in plain sight:
Treating tobacco dependency in the NHS” <span class="citation">(<a href="#ref-RCP2018" role="doc-biblioref">Tobacco Advisory Group of the
Royal College of Physicians 2018</a>)</span>, which reviewed
smoking–disease associations to produce an updated list of diseases that
are caused by smoking and updated risk sources. We mainly keep to the
RCP report’s disease list, with any deviations from the RCP list and
risk sources being for one of two reasons:</p>
<ol style="list-style-type: decimal">
<li><p>There are often slightly conflicting ICD-10 code definitions used
for some conditions and we have sought to harmonise these consistently
across both tobacco and alcohol, based on the Sheffield Alcohol Policy
Model (SAPM) v4.0 disease list <span class="citation">(<a href="#ref-Angus2018" role="doc-biblioref">Angus et al.
2018</a>)</span>;</p></li>
<li><p>Since publication of the RCP report, Cancer Research UK (CRUK)
produced their own disease list and risk sources for cancers
attributable to modifiable risk factors, including tobacco and alcohol
<span class="citation">(<a href="#ref-Brown2018" role="doc-biblioref">Brown et al. 2018</a>)</span>. Discussions with
CRUK shaped the disease definitions in our updated Sheffield disease
list for alcohol. Where there are differences in the risk sources used
in the RCP report and CRUK’s work, we take the estimate that matches
most closely to our disease definitions, or the more recent
estimate.</p></li>
</ol>
</div>
<div class="section level2">
<h2 id="tobaccoalcohol-interactions-in-disease-risk">Tobacco–Alcohol interactions in disease risk<a class="anchor" aria-label="anchor" href="#tobaccoalcohol-interactions-in-disease-risk"></a>
</h2>
<p>There is limited evidence for the risk of disease in someone who
consumes both tobacco and alcohol (<span class="math inline">\(RR_{ta}\)</span>) being higher than would be
expected from combining the independent risks from tobacco (<span class="math inline">\(RR_t\)</span>) and alcohol (<span class="math inline">\(RRa\)</span>). This additional risk due to
tobacco-alcohol interaction (over and above the combination of the
independent contributions to risk from tobacco and alcohol) can be
expressed as a “synergy factor” (1) <span class="citation">(<a href="#ref-Prabhu2014" role="doc-biblioref">A. Prabhu, Obi, and
Rubenstein 2014</a>; <a href="#ref-Hashibe2009" role="doc-biblioref">Hashibe et al. 2009</a>)</span>.</p>
<p><span class="math display">\[\begin{equation}
SF = \frac{RR_{ta}}{(RR_t - 1) + (RR_a - 1)}
\end{equation}\]</span></p>
<p>We conducted a scoping review across all diseases for which tobacco
and alcohol are causal factors to ascertain the extent of evidence on
interaction effects. We include only interactions with a meta-analysis
of effect size. The only diseases for which we have found suitable
meta-analyses to inform the tobacco–alcohol interaction in risk are
cancers of the oral cavity, pharynx, larynx and oesophagus. To evaluate
the interaction between tobacco and alcohol and the risk of cancer of
the oral cavity, pharynx and larynx, Hashibe et al. <span class="citation">(<a href="#ref-Hashibe2009" role="doc-biblioref">2009</a>)</span> conducted a pooled analysis within
the INHANCE consortium. For the oral cavity and pharynx, the SF was
estimated to be 3.09 (CI 1.82–5.23) i.e. smoking and drinking together
causes around a 3-fold increase in the risk of head and neck cancers
over and about the independent contributions of tobacco and alcohol. For
cancer of the larynx, Hashibe et al. <span class="citation">(<a href="#ref-Hashibe2009" role="doc-biblioref">2009</a>)</span> estimate
the SF to be 1.62 (CI 0.85–3.09). For cancer of the oesophagus, Prabhu
et al. <span class="citation">(<a href="#ref-Prabhu2014" role="doc-biblioref">A. Prabhu, Obi, and Rubenstein 2014</a>)</span>
estimated the increase in risk of Squamous Cell Carcinoma in people who
both smoke and drink to be characterised by a synergy factor of 1.85 (CI
1.45–2.38).</p>
<div class="figure" style="text-align: center">
<img src="Smoking_and_the_risks_of_adult_diseases_files/figure-html/smkrelrisks-1.png" alt="Relative risks and 95 percent confidence intervals in current smokers for 52 conditions attributable to smoking." width="768"><p class="caption">
Relative risks and 95 percent confidence intervals in current smokers
for 52 conditions attributable to smoking.
</p>
</div>
</div>
<div class="section level2">
<h2 id="cancers">Cancers<a class="anchor" aria-label="anchor" href="#cancers"></a>
</h2>
<p>We include all cancers attributable to tobacco as mentioned by CRUK
<span class="citation">(<a href="#ref-Brown2018" role="doc-biblioref">Brown et al. 2018</a>)</span>, except ovarian
cancer. Smoking only carries a risk for fully malignant mucinous ovarian
cancers (13% of ovarian cancers are mucinous, and of these 57% are fully
malignant). We excluded ovarian cancer due to the uncertainty involved
in identifying the cases attributable to smoking based on the ICD-10
definitions used in our mortality data and hospital episode
statistics.</p>
<p>Below we itemise each cancer type and explain how we have synthesised
the definitions of cancers and the sources for the relative risk of
smoking among the Sheffield alcohol disease list <span class="citation">(<a href="#ref-Angus2018" role="doc-biblioref">Angus et
al. 2018</a>)</span>, RCP report <span class="citation">(<a href="#ref-RCP2018" role="doc-biblioref">Tobacco Advisory Group of the
Royal College of Physicians 2018</a>)</span>, and CRUK’s paper <span class="citation">(<a href="#ref-Brown2018" role="doc-biblioref">Brown et
al. 2018</a>)</span>.</p>
<div class="section level3">
<h3 id="oral-cavity-c00c06-and-pharyngeal-c09-c10-c12c14">Oral cavity (C00–C06), and pharyngeal (C09, C10, C12–C14)<a class="anchor" aria-label="anchor" href="#oral-cavity-c00c06-and-pharyngeal-c09-c10-c12c14"></a>
</h3>
<p>Gandini et al. <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">2008</a>)</span> estimated the relative risk of
smoking for cancer in the oral cavity as 3.43 (95% Confidence Interval
2.37–4.94), and pharyngeal cancers as 6.76 (CI 2.86–16.0). Following
Gandini, the RCP report associated the relative risk from Gandini for
oral cavity (RR 3.43) with ICD10 code C10, and relative risk for
pharyngeal cancer (RR 6.76) with ICD10 code C14. But in line with CRUK,
we instead use the risk that Gandini associated with oral cavity cancer
(RR 3.43) for pharyngeal cancers with ICD10 codes C09, C10, C12–C14. For
oral cavity, we use the risk from Maasland et al. <span class="citation">(<a href="#ref-Maasland2014" role="doc-biblioref">2014</a>)</span> of 1.91 (CI 1.06–3.42) with ICD10
codes C00–C06.</p>
</div>
<div class="section level3">
<h3 id="oesophageal-c15">Oesophageal (C15)<a class="anchor" aria-label="anchor" href="#oesophageal-c15"></a>
</h3>
<p>Gandini et al. <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">2008</a>)</span> estimated the relative risks of
smoking for cancer of the oesophagus as 2.50 (CI 2.00–3.13). Differing
from the RCP report but in-line with CRUK, we split oesophageal cancer
into its two main histological types: Squamous Cell Carcinoma (SCC) and
Adenocarcinoma (AC). CRUK use different relative risks of smoking for
each subtype: following CRUK, for SCC, we use the risk from Prabhu et
al. <span class="citation">(<a href="#ref-Prabhu2013" role="doc-biblioref">2013</a>)</span> of 4.21 (CI 3.13–5.66); for AC, we
use the risk from Tramacere et al. <span class="citation">(<a href="#ref-Tramacere2011" role="doc-biblioref">2011</a>)</span> of 2.32
(CI 1.96–2.75). We apportion overall oesophageal cancer prevalence
between AC and SCC using data on percentage prevalence by age and sex
from cancer registries, supplied to us by CRUK.</p>
</div>
<div class="section level3">
<h3 id="colorectal-c18c20">Colorectal (C18–C20)<a class="anchor" aria-label="anchor" href="#colorectal-c18c20"></a>
</h3>
<p>The RCP report used the CHANCES consortium <span class="citation">(<a href="#ref-Ordonez-Mena2016" role="doc-biblioref">Ordóñez-Mena et al.
2016</a>)</span> estimate of the relative risk of smoking for colorectal
cancer of 1.20 (CI 1.07–1.34). CRUK instead use the estimates of Cheng
et al. <span class="citation">(<a href="#ref-Cheng2015" role="doc-biblioref">J. Cheng et al. 2015</a>)</span>, who produce two
separate risks of smoking for cancer of the colon and rectum (RR 1.11,
1.44). To align with the SAPM disease list, we define colorectal cancer
as a single disease and use the CHANCES risk estimate in-line with the
RCP report.</p>
</div>
<div class="section level3">
<h3 id="liver-c22">Liver (C22)<a class="anchor" aria-label="anchor" href="#liver-c22"></a>
</h3>
<p>The RCP report used Lee et al.’s <span class="citation">(<a href="#ref-Lee2009" role="doc-biblioref">2009</a>)</span> estimate of
the risk of smoking for liver cancer of 1.51 (CI 1.37–1.67). CRUK use
the same source but take the sex-specific effects: 1.61 (CI 1.38–1.89)
for males and 1.86 (CI 1.33–2.60) for females. Due to the substantial
overlap between the sex-specific confidence intervals, we use the
overall estimate.</p>
</div>
<div class="section level3">
<h3 id="pancreatic-c25">Pancreatic (C25)<a class="anchor" aria-label="anchor" href="#pancreatic-c25"></a>
</h3>
<p>CRUK used Bosetti et al.’s <span class="citation">(<a href="#ref-Bosetti2011" role="doc-biblioref">2011</a>)</span> estimate
from the PanC4 study that the risk of smoking for pancreatic cancer is
2.20 (CI 1.71–2.83). The RCP report used the CHANCES consortium <span class="citation">(<a href="#ref-Ordonez-Mena2016" role="doc-biblioref">Ordóñez-Mena et al. 2016</a>)</span> estimate of
1.90 (CI 1.48–2.43), and we use this more recent estimate.</p>
</div>
<div class="section level3">
<h3 id="laryngeal-c32">Laryngeal (C32)<a class="anchor" aria-label="anchor" href="#laryngeal-c32"></a>
</h3>
<p>The RCP report used Gandini et al.’s <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">2008</a>)</span> estimate
for the relative risks of smoking for cancer of the larynx of 6.98 (CI
3.14–15.52). CRUK used the more recent estimate by Zuo et al. <span class="citation">(<a href="#ref-Zuo2017" role="doc-biblioref">2017</a>)</span> of 7.01 (CI 5.56–8.85). We use the
estimate of Zuo.</p>
</div>
<div class="section level3">
<h3 id="stomach-c16">Stomach (C16)<a class="anchor" aria-label="anchor" href="#stomach-c16"></a>
</h3>
<p>CRUK used the estimate of Ladeiras-Lopes et al. <span class="citation">(<a href="#ref-Ladeiras-Lopes2008" role="doc-biblioref">Ladeiras-Lopes et al. 2008</a>)</span> that put the
relative risk of stomach cancer among smokers at 1.62 (CI 1.50–1.75) for
males and 1.20 (CI 1.01–1.43) for females. The RCP report used the
CHANCES consortium <span class="citation">(<a href="#ref-Ordonez-Mena2016" role="doc-biblioref">Ordóñez-Mena et al.
2016</a>)</span> estimate of 1.74 (CI 1.50–2.02), and estimates from
Gandini et al. <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">2008</a>)</span> are similar. We use the CHANCES
estimate.</p>
</div>
<div class="section level3">
<h3 id="lung-c33c34">Lung (C33–C34)<a class="anchor" aria-label="anchor" href="#lung-c33c34"></a>
</h3>
<p>CRUK used Gandini et al.’s <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">2008</a>)</span> estimate
of the relative risk of lung cancer among smokers of 8.96 (CI
6.73–12.11). The RCP report used the more recent 2016 meta-analysis by
Jayes et al. <span class="citation">(<a href="#ref-Jayes2016" role="doc-biblioref">2016</a>)</span> estimates the risk to be 10.92 (CI
8.28–14.40). We use the Jayes estimate.</p>
</div>
<div class="section level3">
<h3 id="cervical-c53">Cervical (C53)<a class="anchor" aria-label="anchor" href="#cervical-c53"></a>
</h3>
<p>Both CRUK and the RCP report use Gandini et al.’s <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">2008</a>)</span> estimate of the relative risk of
cervix cancer among smokers of 1.83 (CI 1.51–2.21).</p>
</div>
<div class="section level3">
<h3 id="kidney-c64">Kidney (C64)<a class="anchor" aria-label="anchor" href="#kidney-c64"></a>
</h3>
<p>The RCP report used Gandini et al.’s <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">2008</a>)</span> estimate
of the relative risk of kidney cancer among smokers of 1.52 (CI
1.33–1.74). CRUK use the more recent meta-analysis by Cumberbatch et al.
<span class="citation">(<a href="#ref-Cumberbatch2016" role="doc-biblioref">2016</a>)</span> of 1.35 (CI 1.13–1.60) but
associate this with ICD10 codes C64–C66, C68. We use the Cumberbatch
estimate for C64.</p>
</div>
<div class="section level3">
<h3 id="lower-urinary-tract-c65c66">Lower urinary tract (C65–C66)<a class="anchor" aria-label="anchor" href="#lower-urinary-tract-c65c66"></a>
</h3>
<p>In-line with the RCP report, we use Gandini et al.’s <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">2008</a>)</span> estimate of the relative risk of
lower urinary tract (renal pelvis, bladder and ureter) cancer of 2.77
(CI 2.17–3.54).</p>
</div>
<div class="section level3">
<h3 id="bladder-c67">Bladder (C67)<a class="anchor" aria-label="anchor" href="#bladder-c67"></a>
</h3>
<p>The RCP report used the estimate by van Osch et al. <span class="citation">(<a href="#ref-Osch2016" role="doc-biblioref">2016</a>)</span> for the risk of bladder cancer
among smokers of 3.14 (CI 2.53–3.75). CRUK used the same source but took
the sex-specific estimates of 3.44 (CI 2.67–4.22) for males, and 3.56
(CI 2.76–4.36) for females. We use the overall estimate.</p>
</div>
<div class="section level3">
<h3 id="acute-myeloid-leukaemia-c92">Acute myeloid leukaemia (C92)<a class="anchor" aria-label="anchor" href="#acute-myeloid-leukaemia-c92"></a>
</h3>
<p>CRUK used Fircanis et al.’s <span class="citation">(<a href="#ref-Fircanis2014" role="doc-biblioref">2014</a>)</span> estimate
of the relative risk of acute myeloid leukaemia among smokers of 1.47
(CI 1.08–1.98) but associate it with ICD10 codes C90–C95. The RCP report
used the more recent meta-analysis by Colamesta et al. <span class="citation">(<a href="#ref-Colamesta2016" role="doc-biblioref">2016</a>)</span>, which produced a similar estimate
of 1.36 (CI 1.11–1.66). In-line with the RCP report, we use the
Colamesta estimate and associate it with ICD10 code C92.</p>
</div>
<div class="section level3">
<h3 id="nasal-sinuses-and-nasopharynx-c11-c30c31">Nasal-sinuses and nasopharynx (C11, C30–C31)<a class="anchor" aria-label="anchor" href="#nasal-sinuses-and-nasopharynx-c11-c30c31"></a>
</h3>
<p>The RCP report and CRUK both used Gandini et al.’s <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">2008</a>)</span> estimate of the relative risk of
smoking for nasopharyngeal (C11) and sino-nasal (C30, C31) cancers of
1.95 (CI 1.31–2.91).</p>
</div>
</div>
<div class="section level2">
<h2 id="cardiovascular-conditions">Cardiovascular conditions<a class="anchor" aria-label="anchor" href="#cardiovascular-conditions"></a>
</h2>
<p>Our cardiovascular disease list and risk sources are all in-line with
the RCP report, which discusses the sources available. To align with the
Sheffield alcohol disease list, we split stroke into haemorrhagic
(I60–I62) and ischaemic (I63–I67) but use the same smoking risk for
each.</p>
</div>
<div class="section level2">
<h2 id="respiratory-conditions">Respiratory conditions<a class="anchor" aria-label="anchor" href="#respiratory-conditions"></a>
</h2>
<p>Our respiratory disease list and risk sources are all in-line with
the RCP report. We expand the definition of ‘Lower respiratory tract
infections’ (J09-J18) from the Sheffield alcohol disease list to
accommodate the different risks of smoking that the RCP report
identified for pneumonia (J12-J18), Influenza – clinically diagnosed
(J11), and Influenza – microbiologically confirmed (J09, J10).</p>
</div>
<div class="section level2">
<h2 id="mental-health">Mental health<a class="anchor" aria-label="anchor" href="#mental-health"></a>
</h2>
<p>Our mental health disease list and risk sources are all in-line with
the RCP report.</p>
</div>
<div class="section level2">
<h2 id="other-adult-diseases">Other adult diseases<a class="anchor" aria-label="anchor" href="#other-adult-diseases"></a>
</h2>
<p>We include 13 further diseases in-line with the RCP report.</p>
</div>
<div class="section level2">
<h2 id="conditions-less-common-among-smokers">Conditions less common among smokers<a class="anchor" aria-label="anchor" href="#conditions-less-common-among-smokers"></a>
</h2>
<p>We include 2 diseases in-line with the RCP report.</p>
</div>
<div class="section level2">
<h2 id="decline-in-risk-over-time-after-quitting-smoking">Decline in risk over time after quitting smoking<a class="anchor" aria-label="anchor" href="#decline-in-risk-over-time-after-quitting-smoking"></a>
</h2>
<p>To estimate the risk of disease for former smokers we used the
findings of Kontis et al. <span class="citation">(<a href="#ref-Kontis2014" role="doc-biblioref">2014</a>)</span>, who
re-analysed the change in risk after smoking in the ACS-CPS II study
from Oza et al.<span class="citation">(<a href="#ref-Oza2011" role="doc-biblioref">2011</a>)</span>, producing three functions to
describe the decline in risk after quitting for each of cancers, CVD and
COPD (Figure @ref(fig:smklags)). The estimates were informed by data on
former smokers with known quit dates who were disease-free at baseline.
The results show the proportion of excess relative risk remaining at
each time-point since cessation. A cross-check showed that the figures
for cancers were broadly consistent with the findings of the
International Agency for Research on Cancer’s (IARC) 2007 review of the
decline in risk after quitting smoking <span class="citation">(<a href="#ref-IARCWHO2007" role="doc-biblioref">International Agency for
Research on Cancer and World Health Organization 2007</a>)</span>.</p>
<p>The remaining question is how risk declines after quitting smoking
for diseases that are not cancers, CVD or COPD. Kontis et al. <span class="citation">(<a href="#ref-Kontis2014" role="doc-biblioref">2014</a>)</span> state that “Randomised trials also
indicate that the benefits of behaviour change and pharmacological
treatment on diabetes risk occur within a few years, more similar to the
CVDs than cancers <span class="citation">(<a href="#ref-Knowler2002" role="doc-biblioref">Knowler et al. 2002</a>)</span>. Therefore, we used
the CVD curve for diabetes.” In-line with Kontis, we apply the rate of
decline in risk of CVD after quitting smoking to type 2 diabetes. For
other diseases, we assume that the relative risk reverts to 1
immediately after quitting i.e. an immediate rather than a gradual
decline in risk.</p>
<div class="figure" style="text-align: center">
<img src="Smoking_and_the_risks_of_adult_diseases_files/figure-html/smklags-1.png" alt="The proportion of remaining risk after quitting." width="768"><p class="caption">
The proportion of remaining risk after quitting.
</p>
</div>
</div>
<div class="section level2">
<h2 id="tables">Tables<a class="anchor" aria-label="anchor" href="#tables"></a>
</h2>
<p>(ref:tobcurnevrisk-ref1) <span class="citation">(<a href="#ref-Maasland2014" role="doc-biblioref">Maasland et al.
2014</a>)</span><br>
(ref:tobcurnevrisk-ref2) <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">Gandini et al.
2008</a>)</span><br>
(ref:tobcurnevrisk-ref3) <span class="citation">(<a href="#ref-Jayes2016" role="doc-biblioref">Jayes et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref4) <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">Gandini et al.
2008</a>)</span><br>
(ref:tobcurnevrisk-ref5) <span class="citation">(<a href="#ref-Zuo2017" role="doc-biblioref">Zuo et al. 2017</a>)</span><br>
(ref:tobcurnevrisk-ref6) <span class="citation">(<a href="#ref-Tramacere2011" role="doc-biblioref">Tramacere, La Vecchia,
and Negri 2011</a>)</span><br>
(ref:tobcurnevrisk-ref7) <span class="citation">(<a href="#ref-Prabhu2013" role="doc-biblioref">A. Prabhu, Obi, and
Rubenstein 2013</a>)</span><br>
(ref:tobcurnevrisk-ref8) <span class="citation">(<a href="#ref-Ordonez-Mena2016" role="doc-biblioref">Ordóñez-Mena et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref9) <span class="citation">(<a href="#ref-Ordonez-Mena2016" role="doc-biblioref">Ordóñez-Mena et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref10) <span class="citation">(<a href="#ref-Lee2009" role="doc-biblioref">Lee et al. 2009</a>)</span><br>
(ref:tobcurnevrisk-ref11) <span class="citation">(<a href="#ref-Ordonez-Mena2016" role="doc-biblioref">Ordóñez-Mena et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref12) <span class="citation">(<a href="#ref-Cumberbatch2016" role="doc-biblioref">Cumberbatch et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref13) <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">Gandini et al.
2008</a>)</span><br>
(ref:tobcurnevrisk-ref14) <span class="citation">(<a href="#ref-Osch2016" role="doc-biblioref">Osch et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref15) <span class="citation">(<a href="#ref-Gandini2008" role="doc-biblioref">Gandini et al.
2008</a>)</span><br>
(ref:tobcurnevrisk-ref16) <span class="citation">(<a href="#ref-Colamesta2016" role="doc-biblioref">Colamesta et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref17) <span class="citation">(<a href="#ref-Rostron2012" role="doc-biblioref">Rostron
2012</a>)</span><br>
(ref:tobcurnevrisk-ref18) <span class="citation">(<a href="#ref-Peters2013" role="doc-biblioref">Peters, Huxley, and Woodward
2013</a>)</span><br>
(ref:tobcurnevrisk-ref19) <span class="citation">(<a href="#ref-Peters2013" role="doc-biblioref">Peters, Huxley, and Woodward
2013</a>)</span><br>
(ref:tobcurnevrisk-ref20) <span class="citation">(<a href="#ref-Lu2014" role="doc-biblioref">Lu, Mackay, and Pell 2014</a>)</span><br>
(ref:tobcurnevrisk-ref21) <span class="citation">(<a href="#ref-Cornuz2004" role="doc-biblioref">Cornuz et al.
2004</a>)</span><br>
(ref:tobcurnevrisk-ref22) <span class="citation">(<a href="#ref-Cheng2013" role="doc-biblioref">Y.-J. Cheng et al.
2013</a>)</span><br>
(ref:tobcurnevrisk-ref23) <span class="citation">(<a href="#ref-Jayes2016" role="doc-biblioref">Jayes et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref24) <span class="citation">(<a href="#ref-Jayes2016" role="doc-biblioref">Jayes et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref25) <span class="citation">(<a href="#ref-Jayes2016" role="doc-biblioref">Jayes et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref26) <span class="citation">(<a href="#ref-Jayes2016" role="doc-biblioref">Jayes et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref27) <span class="citation">(<a href="#ref-RCP2018" role="doc-biblioref">Tobacco Advisory Group of the Royal College of
Physicians 2018</a>)</span><br>
(ref:tobcurnevrisk-ref28) <span class="citation">(<a href="#ref-RCP2018" role="doc-biblioref">Tobacco Advisory Group of the Royal College of
Physicians 2018</a>)</span><br>
(ref:tobcurnevrisk-ref29) <span class="citation">(<a href="#ref-RCP2018" role="doc-biblioref">Tobacco Advisory Group of the Royal College of
Physicians 2018</a>)</span><br>
(ref:tobcurnevrisk-ref30) <span class="citation">(<a href="#ref-Taskar2006" role="doc-biblioref">Taskar and Coultas
2006</a>)</span><br>
(ref:tobcurnevrisk-ref31) <span class="citation">(<a href="#ref-Pan2015" role="doc-biblioref">Pan et al. 2015</a>)</span><br>
(ref:tobcurnevrisk-ref32) <span class="citation">(<a href="#ref-Zhong2015" role="doc-biblioref">Zhong et al.
2015</a>)</span><br>
(ref:tobcurnevrisk-ref33) <span class="citation">(<a href="#ref-Zhang2016" role="doc-biblioref">Zhang et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref34) <span class="citation">(<a href="#ref-Breckenridge2016" role="doc-biblioref">Breckenridge et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref35) <span class="citation">(<a href="#ref-Zhong2015" role="doc-biblioref">Zhong et al.
2015</a>)</span><br>
(ref:tobcurnevrisk-ref36) <span class="citation">(<a href="#ref-Zhong2015" role="doc-biblioref">Zhong et al.
2015</a>)</span><br>
(ref:tobcurnevrisk-ref37) <span class="citation">(<a href="#ref-Luger2014" role="doc-biblioref">Luger, Suls, and Vander Weg
2014</a>)</span><br>
(ref:tobcurnevrisk-ref38) <span class="citation">(<a href="#ref-RCP2018" role="doc-biblioref">Tobacco Advisory Group of the Royal College of
Physicians 2018</a>)</span><br>
(ref:tobcurnevrisk-ref39) <span class="citation">(<a href="#ref-Gurillo2015" role="doc-biblioref">Gurillo et al.
2015</a>)</span><br>
(ref:tobcurnevrisk-ref40) <span class="citation">(<a href="#ref-Solmi2016" role="doc-biblioref">Solmi et al.
2016</a>)</span><br>
(ref:tobcurnevrisk-ref41) <span class="citation">(<a href="#ref-Jiang2015" role="doc-biblioref">Jiang, Li, and Jia
2015</a>)</span><br>
(ref:tobcurnevrisk-ref42) <span class="citation">(<a href="#ref-Shiri2010" role="doc-biblioref">Shiri et al.
2010</a>)</span><br>
(ref:tobcurnevrisk-ref43) <span class="citation">(<a href="#ref-DiGiuseppe2014" role="doc-biblioref">Di Giuseppe et al.
2014</a>)</span><br>
(ref:tobcurnevrisk-ref44) <span class="citation">(<a href="#ref-Armstrong2014" role="doc-biblioref">Armstrong et al.
2014</a>)</span><br>
(ref:tobcurnevrisk-ref45) <span class="citation">(<a href="#ref-Chakravarthy2010" role="doc-biblioref">Chakravarthy et al.
2010</a>)</span><br>
(ref:tobcurnevrisk-ref46) <span class="citation">(<a href="#ref-Ye2012" role="doc-biblioref">Ye et al. 2012</a>)</span><br>
(ref:tobcurnevrisk-ref47) <span class="citation">(<a href="#ref-Mahid2006" role="doc-biblioref">Mahid et al.
2006</a>)</span><br>
(ref:tobcurnevrisk-ref48) <span class="citation">(<a href="#ref-Dias2015" role="doc-biblioref">Dias et al.
2015</a>)</span><br>
(ref:tobcurnevrisk-ref49) <span class="citation">(<a href="#ref-Shen2015" role="doc-biblioref">Shen et al.
2015</a>)</span><br>
(ref:tobcurnevrisk-ref50) <span class="citation">(<a href="#ref-Xia2017" role="doc-biblioref">Xia et al. 2017</a>)</span><br>
(ref:tobcurnevrisk-ref51) <span class="citation">(<a href="#ref-Xia2017" role="doc-biblioref">Xia et al. 2017</a>)</span><br>
(ref:tobcurnevrisk-ref52) <span class="citation">(<a href="#ref-Nomura2005" role="doc-biblioref">Nomura, Nakao, and Morimoto
2005</a>)</span></p>
<table class="table table" style="font-size: 8px; margin-left: auto; margin-right: auto;">
<caption style="font-size: initial !important;">
Disease definitions and risk functions (with 95 percent confidence
intervals) for current vs. never smoking.
</caption>
<thead><tr>
<th style="text-align:left;">
Category
</th>
<th style="text-align:left;">
Disease
</th>
<th style="text-align:left;">
ICD-10
</th>
<th style="text-align:left;">
Relative risk
</th>
<th style="text-align:left;">
Source
</th>
</tr></thead>
<tbody>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Oral cavity
</td>
<td style="text-align:left;width: 3cm; ">
C00-C06
</td>
<td style="text-align:left;width: 3cm; ">
1.91 (1.06–3.42)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref1)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Pharynx
</td>
<td style="text-align:left;width: 3cm; ">
C09, C10, C12-C14
</td>
<td style="text-align:left;width: 3cm; ">
3.43 (2.37–4.94)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref2)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Lung
</td>
<td style="text-align:left;width: 3cm; ">
C33, C34
</td>
<td style="text-align:left;width: 3cm; ">
10.92 (8.28–14.40)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref3)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Nasopharynx sinonasal
</td>
<td style="text-align:left;width: 3cm; ">
C11, C30, C31
</td>
<td style="text-align:left;width: 3cm; ">
1.95 (1.31–2.91)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref4)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Larynx
</td>
<td style="text-align:left;width: 3cm; ">
C32
</td>
<td style="text-align:left;width: 3cm; ">
7.01 (5.56–8.85)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref5)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Oesophageal (Adenocarcinoma)
</td>
<td style="text-align:left;width: 3cm; ">
C15
</td>
<td style="text-align:left;width: 3cm; ">
2.32 (1.96–2.75)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref6)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Oesophageal (Squamous cell carcinoma)
</td>
<td style="text-align:left;width: 3cm; ">
C15
</td>
<td style="text-align:left;width: 3cm; ">
4.21 (3.13–5.66)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref7)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Stomach
</td>
<td style="text-align:left;width: 3cm; ">
C16
</td>
<td style="text-align:left;width: 3cm; ">
1.74 (1.50–2.02)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref8)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Pancreas
</td>
<td style="text-align:left;width: 3cm; ">
C25
</td>
<td style="text-align:left;width: 3cm; ">
1.90 (1.48–2.43)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref9)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Liver
</td>
<td style="text-align:left;width: 3cm; ">
C22
</td>
<td style="text-align:left;width: 3cm; ">
1.51 (1.37–1.67)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref10)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Colorectal
</td>
<td style="text-align:left;width: 3cm; ">
C18-C20
</td>
<td style="text-align:left;width: 3cm; ">
1.20 (1.07–1.34)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref11)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Kidney
</td>
<td style="text-align:left;width: 3cm; ">
C64
</td>
<td style="text-align:left;width: 3cm; ">
1.35 (1.13–1.60)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref12)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Lower urinary tract
</td>
<td style="text-align:left;width: 3cm; ">
C65, C66
</td>
<td style="text-align:left;width: 3cm; ">
2.77 (2.17–3.54)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref13)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Bladder
</td>
<td style="text-align:left;width: 3cm; ">
C67
</td>
<td style="text-align:left;width: 3cm; ">
3.14 (2.53–3.75)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref14)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Cervical
</td>
<td style="text-align:left;width: 3cm; ">
C53
</td>
<td style="text-align:left;width: 3cm; ">
1.83 (1.51–2.21)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref15)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Malignant neoplasms
</td>
<td style="text-align:left;width: 3cm; ">
Acute myeloid leukaemia
</td>
<td style="text-align:left;width: 3cm; ">
C92
</td>
<td style="text-align:left;width: 3cm; ">
1.36 (1.11–1.66)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref16)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Circulatory system
</td>
<td style="text-align:left;width: 3cm; ">
Ischaemic heart disease
</td>
<td style="text-align:left;width: 3cm; ">
I20-I25
</td>
<td style="text-align:left;width: 3cm; ">
Male 35–64: 3.18 (2.34–4.33), Male 65+: 1.96 (1.62–2.37), Female 35–64:
3.93 (2.56–6.05), Female 65+: 1.95 (1.60–2.37)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref17)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Circulatory system
</td>
<td style="text-align:left;width: 3cm; ">
Haemorrhagic stroke
</td>
<td style="text-align:left;width: 3cm; ">
I60-I62
</td>
<td style="text-align:left;width: 3cm; ">
Male: 1.57 (1.49–1.88), Female: 1.83 (1.58–2.12)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref18)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Circulatory system
</td>
<td style="text-align:left;width: 3cm; ">
Ischaemic stroke
</td>
<td style="text-align:left;width: 3cm; ">
I63-I67
</td>
<td style="text-align:left;width: 3cm; ">
Male: 1.57 (1.49–1.88), Female: 1.83 (1.58–2.12)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref19)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Circulatory system
</td>
<td style="text-align:left;width: 3cm; ">
Peripheral arterial disease
</td>
<td style="text-align:left;width: 3cm; ">
I73.9
</td>
<td style="text-align:left;width: 3cm; ">
2.71 (2.28–3.21)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref20)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Circulatory system
</td>
<td style="text-align:left;width: 3cm; ">
Abdominal aortic aneurysm
</td>
<td style="text-align:left;width: 3cm; ">
I71
</td>
<td style="text-align:left;width: 3cm; ">
2.41 (1.94–3.01)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref21)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Circulatory system
</td>
<td style="text-align:left;width: 3cm; ">
Venous thromboembolism
</td>
<td style="text-align:left;width: 3cm; ">
I26,I80-I82
</td>
<td style="text-align:left;width: 3cm; ">
1.23 (1.14–1.33)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref22)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Respiratory system
</td>
<td style="text-align:left;width: 3cm; ">
Chronic obstructive pulmonary disease
</td>
<td style="text-align:left;width: 3cm; ">
J40-J44,J47
</td>
<td style="text-align:left;width: 3cm; ">
4.01 (3.18–5.05)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref23)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Respiratory system
</td>
<td style="text-align:left;width: 3cm; ">
Asthma
</td>
<td style="text-align:left;width: 3cm; ">
J45-J46
</td>
<td style="text-align:left;width: 3cm; ">
1.61 (1.07–2.42)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref24)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Respiratory system
</td>
<td style="text-align:left;width: 3cm; ">
Tuberculosis
</td>
<td style="text-align:left;width: 3cm; ">
A15-A19
</td>
<td style="text-align:left;width: 3cm; ">
1.57 (1.18–2.10)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref25)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Respiratory system
</td>
<td style="text-align:left;width: 3cm; ">
Obstructive sleep apnoea
</td>
<td style="text-align:left;width: 3cm; ">
G47.3
</td>
<td style="text-align:left;width: 3cm; ">
1.97 (1.02–3.82)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref26)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Respiratory system
</td>
<td style="text-align:left;width: 3cm; ">
Pneumonia
</td>
<td style="text-align:left;width: 3cm; ">
J12-J18
</td>
<td style="text-align:left;width: 3cm; ">
2.18 (1.69–2.80)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref27)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Respiratory system
</td>
<td style="text-align:left;width: 3cm; ">
Influenza (clinically diagnosed)
</td>
<td style="text-align:left;width: 3cm; ">
J11
</td>
<td style="text-align:left;width: 3cm; ">
1.34 (1.13–1.59)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref28)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Respiratory system
</td>
<td style="text-align:left;width: 3cm; ">
Influenza (microbiologically confirmed)
</td>
<td style="text-align:left;width: 3cm; ">
J09, J10
</td>
<td style="text-align:left;width: 3cm; ">
5.69 (2.79–11.60)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref29)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Respiratory system
</td>
<td style="text-align:left;width: 3cm; ">
Idiopathic pulmonary fibrosis
</td>
<td style="text-align:left;width: 3cm; ">
J84.1
</td>
<td style="text-align:left;width: 3cm; ">
1.58 (1.27–1.97)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref30)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Mental health
</td>
<td style="text-align:left;width: 3cm; ">
Alzheimers disease
</td>
<td style="text-align:left;width: 3cm; ">
G30
</td>
<td style="text-align:left;width: 3cm; ">
1.40 (1.13–1.73)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref32)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Mental health
</td>
<td style="text-align:left;width: 3cm; ">
Vascular dementia
</td>
<td style="text-align:left;width: 3cm; ">
F01
</td>
<td style="text-align:left;width: 3cm; ">
1.38 (1.15–1.66)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref35)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Mental health
</td>
<td style="text-align:left;width: 3cm; ">
All cause dementia
</td>
<td style="text-align:left;width: 3cm; ">
F02,F03
</td>
<td style="text-align:left;width: 3cm; ">
1.30 (1.18–1.45)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref36)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Mental health
</td>
<td style="text-align:left;width: 3cm; ">
Depression
</td>
<td style="text-align:left;width: 3cm; ">
F32,F33
</td>
<td style="text-align:left;width: 3cm; ">
1.62 (1.10–2.40)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref37)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Mental health
</td>
<td style="text-align:left;width: 3cm; ">
Psychosis
</td>
<td style="text-align:left;width: 3cm; ">
F28,F29
</td>
<td style="text-align:left;width: 3cm; ">
2.18 (1.23–3.85)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref39)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Mental health
</td>
<td style="text-align:left;width: 3cm; ">
Schizophrenia
</td>
<td style="text-align:left;width: 3cm; ">
F20-F25
</td>
<td style="text-align:left;width: 3cm; ">
2.24 (1.10–4.55)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref38)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Mental health
</td>
<td style="text-align:left;width: 3cm; ">
Bulimia
</td>
<td style="text-align:left;width: 3cm; ">
F50.2
</td>
<td style="text-align:left;width: 3cm; ">
2.32 (1.12–4.78)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref40)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Diabetes (type 2)
</td>
<td style="text-align:left;width: 3cm; ">
E11
</td>
<td style="text-align:left;width: 3cm; ">
1.37 (1.33–1.42)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref31)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Multiple sclerosis
</td>
<td style="text-align:left;width: 3cm; ">
G35
</td>
<td style="text-align:left;width: 3cm; ">
1.55 (1.48–1.62)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref33)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Systematic lupus erythematosis
</td>
<td style="text-align:left;width: 3cm; ">
M32
</td>
<td style="text-align:left;width: 3cm; ">
1.56 (1.26–1.95)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref41)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Low back pain
</td>
<td style="text-align:left;width: 3cm; ">
M54
</td>
<td style="text-align:left;width: 3cm; ">
1.16 (1.02–1.32)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref42)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Rheumatoid arthritis
</td>
<td style="text-align:left;width: 3cm; ">
M05,M06
</td>
<td style="text-align:left;width: 3cm; ">
2.02 (1.75–2.33)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref43)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Psoriasis
</td>
<td style="text-align:left;width: 3cm; ">
L40
</td>
<td style="text-align:left;width: 3cm; ">
1.78 (1.52–2.06)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref44)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Age related macular degeneration
</td>
<td style="text-align:left;width: 3cm; ">
H35.3-H52.4
</td>
<td style="text-align:left;width: 3cm; ">
1.86 (1.27–2.73)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref45)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Senile cataract
</td>
<td style="text-align:left;width: 3cm; ">
H25
</td>
<td style="text-align:left;width: 3cm; ">
1.47 (1.36–1.59)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref46)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Crohns disease
</td>
<td style="text-align:left;width: 3cm; ">
K50
</td>
<td style="text-align:left;width: 3cm; ">
1.76 (1.40–2.22)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref47)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Hip fracture
</td>
<td style="text-align:left;width: 3cm; ">
S72.0-S72.2
</td>
<td style="text-align:left;width: 3cm; ">
1.30 (1.16–1.45)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref49)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Chronic kidney disease
</td>
<td style="text-align:left;width: 3cm; ">
N18.1,N18.2,N18.3, N18.4,N18.8,N18.9
</td>
<td style="text-align:left;width: 3cm; ">
1.34 (1.23–1.47)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref50)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
End-stage renal disease
</td>
<td style="text-align:left;width: 3cm; ">
N18.5,N18.0
</td>
<td style="text-align:left;width: 3cm; ">
1.91 (1.39–2.64)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref51)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Other adult diseases
</td>
<td style="text-align:left;width: 3cm; ">
Hearing loss
</td>
<td style="text-align:left;width: 3cm; ">
H90,H91
</td>
<td style="text-align:left;width: 3cm; ">
1.97 (1.44–2.70)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref52)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Conditions less common among smokers
</td>
<td style="text-align:left;width: 3cm; ">
Ulcerative colitis
</td>
<td style="text-align:left;width: 3cm; ">
K51
</td>
<td style="text-align:left;width: 3cm; ">
0.55 (0.33–0.91)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref48)
</td>
</tr>
<tr>
<td style="text-align:left;width: 2cm; ">
Conditions less common among smokers
</td>
<td style="text-align:left;width: 3cm; ">
Parkinson
</td>
<td style="text-align:left;width: 3cm; ">
G20
</td>
<td style="text-align:left;width: 3cm; ">
0.46 (0.42–0.51)
</td>
<td style="text-align:left;width: 4cm; ">
(ref:tobcurnevrisk-ref34)
</td>
</tr>
</tbody>
</table>
</div>
<div class="section level2">
<h2 class="unnumbered" id="references">References<a class="anchor" aria-label="anchor" href="#references"></a>
</h2>
<div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-Angus2018" class="csl-entry">
Angus, Colin, M Henney, L Webster, and Duncan Gillespie. 2018.
<span>“Alcohol-Attributable Diseases and Dose-Response Curves for the
Sheffield Alcohol Policy Model Version 4.0.”</span> <a href="https://doi.org/10.15131/shef.data.6819689.v1" class="external-link">https://doi.org/10.15131/shef.data.6819689.v1</a>.
</div>
<div id="ref-Armstrong2014" class="csl-entry">
Armstrong, A. W., C. T. Harskamp, J. S. Dhillon, and E. J. Armstrong.
2014. <span>“Psoriasis and Smoking: A Systematic Review and
Meta-Analysis.”</span> Journal Article. <em>Br J Dermatol</em> 170 (2):
304–14. <a href="https://doi.org/10.1111/bjd.12670" class="external-link">https://doi.org/10.1111/bjd.12670</a>.
</div>
<div id="ref-Bosetti2011" class="csl-entry">
Bosetti, C, E Lucenteforte, DT Silverman, G Petersen, PM Bracci, BT Ji,
E Negri, D Li, HA Risch, and SH Olson. 2011. <span>“Cigarette Smoking
and Pancreatic Cancer: An Analysis from the International Pancreatic
Cancer Case-Control Consortium (Panc4).”</span> Journal Article.
<em>Annals of Oncology</em> 23 (7): 1880–88.
</div>
<div id="ref-Breckenridge2016" class="csl-entry">
Breckenridge, Charles B., Colin Berry, Ellen T. Chang, Jr. Sielken
Robert L., and Jack S. Mandel. 2016. <span>“Association Between
Parkinson’s Disease and Cigarette Smoking, Rural Living, Well-Water
Consumption, Farming and Pesticide Use: Systematic Review and
Meta-Analysis.”</span> Journal Article. <em>PLOS ONE</em> 11 (4):
e0151841. <a href="https://doi.org/10.1371/journal.pone.0151841" class="external-link">https://doi.org/10.1371/journal.pone.0151841</a>.
</div>
<div id="ref-Brown2018" class="csl-entry">
Brown, Katrina F., Harriet Rumgay, Casey Dunlop, Margaret Ryan, Frances
Quartly, Alison Cox, Andrew Deas, et al. 2018. <span>“The Fraction of
Cancer Attributable to Modifiable Risk Factors in England, Wales,
Scotland, Northern Ireland, and the United Kingdom in 2015.”</span>
Journal Article. <em>British Journal of Cancer</em> 118 (8): 1130–41. <a href="https://doi.org/10.1038/s41416-018-0029-6" class="external-link">https://doi.org/10.1038/s41416-018-0029-6</a>.
</div>
<div id="ref-Chakravarthy2010" class="csl-entry">
Chakravarthy, Usha, Tien Y Wong, Astrid Fletcher, Elisabeth Piault,
Christopher Evans, Gergana Zlateva, Ronald Buggage, Andreas Pleil, and
Paul Mitchell. 2010. <span>“Clinical Risk Factors for Age-Related
Macular Degeneration: A Systematic Review and Meta-Analysis.”</span>
Journal Article. <em>BMC Ophthalmology</em> 10 (1): 31.
</div>
<div id="ref-Cheng2015" class="csl-entry">
Cheng, Jiemin, Yi Chen, Xiaolin Wang, Jianhua Wang, Zhiping Yan, Gaoquan
Gong, Guoping Li, and Changyu Li. 2015. <span>“Meta-Analysis of
Prospective Cohort Studies of Cigarette Smoking and the Incidence of
Colon and Rectal Cancers.”</span> Journal Article. <em>European Journal
of Cancer Prevention</em> 24 (1): 6–15.
</div>
<div id="ref-Cheng2013" class="csl-entry">
Cheng, Yun-Jiu, Zhi-Hao Liu, Feng-Juan Yao, Wu-Tao Zeng, Dong-Dan Zheng,
Yu-Gang Dong, and Su-Hua Wu. 2013. <span>“Current and Former Smoking and
Risk for Venous Thromboembolism: A Systematic Review and
Meta-Analysis.”</span> Journal Article. <em>PLoS Medicine</em> 10 (9):
e1001515.
</div>
<div id="ref-Colamesta2016" class="csl-entry">
Colamesta, Vittoria, Silvia D’Aguanno, Massimo Breccia, Sara Bruffa,
Claudio Cartoni, and Giuseppe La Torre. 2016. <span>“Do the Smoking
Intensity and Duration, the Years Since Quitting, the Methodological
Quality and the Year of Publication of the Studies Affect the Results of
the Meta-Analysis on Cigarette Smoking and Acute Myeloid Leukemia (AML)
in Adults?”</span> Journal Article. <em>Critical Reviews in
Oncology/Hematology</em> 99: 376–88.
</div>
<div id="ref-Cornuz2004" class="csl-entry">
Cornuz, Jacques, Claudio Sidoti Pinto, Heindrik Tevaearai, and Matthias
Egger. 2004. <span>“Risk Factors for Asymptomatic Abdominal Aortic
Aneurysm: Systematic Review and Meta-Analysis of Population-Based
Screening Studies.”</span> Journal Article. <em>The European Journal of
Public Health</em> 14 (4): 343–49.
</div>
<div id="ref-Cumberbatch2016" class="csl-entry">
Cumberbatch, Marcus G, Matteo Rota, James WF Catto, and Carlo La
Vecchia. 2016. <span>“The Role of Tobacco Smoke in Bladder and Kidney
Carcinogenesis: A Comparison of Exposures and Meta-Analysis of Incidence
and Mortality Risks.”</span> Journal Article. <em>European Urology</em>
70 (3): 458–66.
</div>
<div id="ref-DiGiuseppe2014" class="csl-entry">
Di Giuseppe, Daniela, Andrea Discacciati, Nicola Orsini, and Alicja
Wolk. 2014. <span>“Cigarette Smoking and Risk of Rheumatoid Arthritis: A
Dose-Response Meta-Analysis.”</span> Journal Article. <em>Arthritis
Research &amp; Therapy</em> 16 (2): R61.
</div>
<div id="ref-Dias2015" class="csl-entry">
Dias, C. C., P. P. Rodrigues, A. da Costa-Pereira, and F. Magro. 2015.
<span>“Clinical Predictors of Colectomy in Patients with Ulcerative
Colitis: Systematic Review and Meta-Analysis of Cohort Studies.”</span>
Journal Article. <em>J Crohns Colitis</em> 9 (2): 156–63. <a href="https://doi.org/10.1093/ecco-jcc/jju016" class="external-link">https://doi.org/10.1093/ecco-jcc/jju016</a>.
</div>
<div id="ref-Fircanis2014" class="csl-entry">
Fircanis, Sophia, Priscilla Merriam, Naushaba Khan, and Jorge J
Castillo. 2014. <span>“The Relation Between Cigarette Smoking and Risk
of Acute Myeloid Leukemia: An Updated Meta‐analysis of Epidemiological
Studies.”</span> Journal Article. <em>American Journal of
Hematology</em> 89 (8): E125–32.
</div>
<div id="ref-Gandini2008" class="csl-entry">
Gandini, Sara, Edoardo Botteri, Simona Iodice, Mathieu Boniol, Albert B
Lowenfels, Patrick Maisonneuve, and Peter Boyle. 2008. <span>“Tobacco
Smoking and Cancer: A Meta‐analysis.”</span> Journal Article.
<em>International Journal of Cancer</em> 122 (1): 155–64. <a href="https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.23033" class="external-link">https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.23033</a>.
</div>
<div id="ref-Gurillo2015" class="csl-entry">
Gurillo, Pedro, Sameer Jauhar, Robin M. Murray, and James H. MacCabe.
2015. <span>“Does Tobacco Use Cause Psychosis? Systematic Review and
Meta-Analysis.”</span> Journal Article. <em>The Lancet Psychiatry</em> 2
(8): 718–25. <a href="https://doi.org/10.1016/S2215-0366(15)00152-2" class="external-link">https://doi.org/10.1016/S2215-0366(15)00152-2</a>.
</div>
<div id="ref-Hashibe2009" class="csl-entry">
Hashibe, M., P. Brennan, S. C. Chuang, S. Boccia, X. Castellsague, C.
Chen, M. P. Curado, et al. 2009. <span>“Interaction Between Tobacco and
Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the
International Head and Neck Cancer Epidemiology Consortium.”</span>
Journal Article. <em>Cancer Epidemiology Biomarkers &amp;
Prevention</em> 18 (2): 541–50. <a href="https://doi.org/10.1158/1055-9965.epi-08-0347" class="external-link">https://doi.org/10.1158/1055-9965.epi-08-0347</a>.
</div>
<div id="ref-IARCWHO2007" class="csl-entry">
International Agency for Research on Cancer and World Health
Organization. 2007. <span>“Reversal of Risk After Quitting
Smoking.”</span> Report.
</div>
<div id="ref-Jayes2016" class="csl-entry">
Jayes, Leah, Patricia L. Haslam, Christina G. Gratziou, Pippa Powell,
John Britton, Constantine Vardavas, Carlos Jimenez-Ruiz, and Jo
Leonardi-Bee. 2016. <span>“SmokeHaz: Systematic Reviews and
Meta-Analyses of the Effects of Smoking on Respiratory Health.”</span>
Journal Article. <em>CHEST Journal</em> 150 (1): 164–79.
</div>
<div id="ref-Jiang2015" class="csl-entry">
Jiang, Fan, Suyun Li, and Chongqi Jia. 2015. <span>“Smoking and the Risk
of Systemic Lupus Erythematosus: An Updated Systematic Review and
Cumulative Meta-Analysis.”</span> Journal Article. <em>Clinical
Rheumatology</em> 34 (11): 1885–92.
</div>
<div id="ref-Knowler2002" class="csl-entry">
Knowler, William C, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F
Hamman, John M Lachin, Elizabeth A Walker, and David M Nathan. 2002.
<span>“Reduction in the Incidence of Type 2 Diabetes with Lifestyle
Intervention or Metformin.”</span> Journal Article. <em>The New England
Journal of Medicine</em> 346 (6): 393–403.
</div>
<div id="ref-Kontis2014" class="csl-entry">
Kontis, Vasilis, Colin D Mathers, Jürgen Rehm, Gretchen A Stevens, Kevin
D Shield, Ruth Bonita, Leanne M Riley, Vladimir Poznyak, Robert
Beaglehole, and Majid Ezzati. 2014. <span>“Contribution of Six Risk
Factors to Achieving the 25× 25 Non-Communicable Disease Mortality
Reduction Target: A Modelling Study.”</span> Journal Article. <em>The
Lancet</em> 384 (9941): 427–37.
</div>
<div id="ref-Ladeiras-Lopes2008" class="csl-entry">
Ladeiras-Lopes, Ricardo, Alexandre Kirchhofer Pereira, Amanda Nogueira,
Tiago Pinheiro-Torres, Isabel Pinto, Ricardo Santos-Pereira, and Nuno
Lunet. 2008. <span>“Smoking and Gastric Cancer: Systematic Review and
Meta-Analysis of Cohort Studies.”</span> Journal Article. <em>Cancer
Causes &amp; Control</em> 19 (7): 689–701.
</div>
<div id="ref-Lee2009" class="csl-entry">
Lee, Yuan-Chin Amy, Catherine Cohet, Yu-Ching Yang, Leslie Stayner, Mia
Hashibe, and Kurt Straif. 2009. <span>“Meta-Analysis of Epidemiologic
Studies on Cigarette Smoking and Liver Cancer.”</span> Journal Article.
<em>International Journal of Epidemiology</em> 38 (6): 1497–1511.
</div>
<div id="ref-Lu2014" class="csl-entry">
Lu, L, DF Mackay, and JP Pell. 2014. <span>“Meta-Analysis of the
Association Between Cigarette Smoking and Peripheral Arterial
Disease.”</span> Journal Article. <em>Heart</em> 100 (5): 414–23.
</div>
<div id="ref-Luger2014" class="csl-entry">
Luger, Tana M., Jerry Suls, and Mark W. Vander Weg. 2014. <span>“How
Robust Is the Association Between Smoking and Depression in Adults? A
Meta-Analysis Using Linear Mixed-Effects Models.”</span> Journal
Article. <em>Addictive Behaviors</em> 39 (10): 1418–29.
https://doi.org/<a href="http://doi.org/10.1016/j.addbeh.2014.05.011" class="external-link">http://doi.org/10.1016/j.addbeh.2014.05.011</a>.
</div>
<div id="ref-Maasland2014" class="csl-entry">
Maasland, Denise HE, Piet A van den Brandt, Bernd Kremer, R Alexandra
Sandra Goldbohm, and Leo J Schouten. 2014. <span>“Alcohol Consumption,
Cigarette Smoking and the Risk of Subtypes of Head-Neck Cancer: Results
from the Netherlands Cohort Study.”</span> Journal Article. <em>BMC
Cancer</em> 14 (1): 187.
</div>
<div id="ref-Mahid2006" class="csl-entry">
Mahid, S. S., K. S. Minor, R. E. Soto, C. A. Hornung, and S. Galandiuk.
2006. <span>“Smoking and Inflammatory Bowel Disease: A
Meta-Analysis.”</span> Journal Article. <em>Mayo Clin Proc</em> 81 (11):
1462–71. <a href="https://doi.org/10.4065/81.11.1462" class="external-link">https://doi.org/10.4065/81.11.1462</a>.
</div>
<div id="ref-Nomura2005" class="csl-entry">
Nomura, Kyoko, Mutsuhiro Nakao, and Takeshi Morimoto. 2005.
<span>“Effect of Smoking on Hearing Loss: Quality Assessment and
Meta-Analysis.”</span> Journal Article. <em>Preventive Medicine</em> 40
(2): 138–44.
</div>
<div id="ref-Ordonez-Mena2016" class="csl-entry">
Ordóñez-Mena, José Manuel, Ben Schöttker, Ute Mons, Mazda Jenab, Heinz
Freisling, Bas Bueno-de-Mesquita, Mark G O’Doherty, Angela Scott, Frank
Kee, and Bruno H Stricker. 2016. <span>“Quantification of the
Smoking-Associated Cancer Risk with Rate Advancement Periods:
Meta-Analysis of Individual Participant Data from Cohorts of the CHANCES
Consortium.”</span> Journal Article. <em>BMC Medicine</em> 14 (1): 62.
</div>
<div id="ref-Osch2016" class="csl-entry">
Osch, Frits HM van, Sylvia HJ Jochems, Frederik-Jan van Schooten,
Richard T Bryan, and Maurice P Zeegers. 2016. <span>“Quantified
Relations Between Exposure to Tobacco Smoking and Bladder Cancer Risk: A
Meta-Analysis of 89 Observational Studies.”</span> Journal Article.
<em>International Journal of Epidemiology</em> 45 (3): 857–70.
</div>
<div id="ref-Oza2011" class="csl-entry">
Oza, Shefali, Michael J Thun, S Jane Henley, Alan D Lopez, and Majid
Ezzati. 2011. <span>“How Many Deaths Are Attributable to Smoking in the
United States? Comparison of Methods for Estimating Smoking-Attributable
Mortality When Smoking Prevalence Changes.”</span> Journal Article.
<em>Preventive Medicine</em> 52 (6): 428–33.
</div>
<div id="ref-Pan2015" class="csl-entry">
Pan, An, Yeli Wang, Mohammad Talaei, Frank B Hu, and Tangchun Wu. 2015.
<span>“Relation of Active, Passive, and Quitting Smoking with Incident
Type 2 Diabetes: A Systematic Review and Meta-Analysis.”</span> Journal
Article. <em>The Lancet Diabetes &amp; Endocrinology</em> 3 (12):
958–67.
</div>
<div id="ref-Peters2013" class="csl-entry">
Peters, Sanne AE, Rachel R Huxley, and Mark Woodward. 2013.
<span>“Smoking as a Risk Factor for Stroke in Women Compared with Men: A
Systematic Review and Meta-Analysis of 81 Cohorts, Including 3 980 359
Individuals and 42 401 Strokes.”</span> Journal Article. <em>Stroke</em>
44 (10): 2821–28.
</div>
<div id="ref-Prabhu2014" class="csl-entry">
Prabhu, A., K. O. Obi, and J. H. Rubenstein. 2014. <span>“The
Synergistic Effects of Alcohol and Tobacco Consumption on the Risk of
Esophageal Squamous Cell Carcinoma: A Meta-Analysis.”</span> Journal
Article. <em>American Journal of Gastroenterology</em> 109 (6): 821–27.
<a href="https://doi.org/10.1038/ajg.2014.71" class="external-link">https://doi.org/10.1038/ajg.2014.71</a>.
</div>
<div id="ref-Prabhu2013" class="csl-entry">
Prabhu, A, KO Obi, and JH Rubenstein. 2013. <span>“Systematic Review
with Meta‐analysis: Race‐specific Effects of Alcohol and Tobacco on the
Risk of Oesophageal Squamous Cell Carcinoma.”</span> Journal Article.
<em>Alimentary Pharmacology &amp; Therapeutics</em> 38 (10): 1145–55.
</div>
<div id="ref-Rostron2012" class="csl-entry">
Rostron, Brian. 2012. <span>“Smoking-Attributable Mortality by Cause in
the United States: Revising the CDC’s Data and Estimates.”</span>
Journal Article. <em>Nicotine &amp; Tobacco Research</em> 15 (1):
238–46.
</div>
<div id="ref-Shen2015" class="csl-entry">
Shen, Guang Si, Yong Li, GuoYang Zhao, Hai Bin Zhou, Zong Gang Xie, Wei
Xu, Hai Nan Chen, Qi Rong Dong, and You Jia Xu. 2015. <span>“Cigarette
Smoking and Risk of Hip Fracture in Women: A Meta-Analysis of
Prospective Cohort Studies.”</span> Journal Article. <em>Injury</em> 46
(7): 1333–40.
</div>
<div id="ref-Shiri2010" class="csl-entry">
Shiri, Rahman, Jaro Karppinen, Päivi Leino-Arjas, Svetlana Solovieva,
and Eira Viikari-Juntura. 2010. <span>“The Association Between Smoking
and Low Back Pain: A Meta-Analysis.”</span> Journal Article. <em>The
American Journal of Medicine</em> 123 (1): 87. e7–35.
</div>
<div id="ref-Solmi2016" class="csl-entry">
Solmi, Marco, Nicola Veronese, Giuseppe Sergi, Claudio Luchini, Angela
Favaro, Paolo Santonastaso, Davy Vancampfort, et al. 2016. <span>“The
Association Between Smoking Prevalence and Eating Disorders: A
Systematic Review and Meta-Analysis.”</span> Journal Article.
<em>Addiction</em> 111 (11): 1914–22. <a href="https://doi.org/10.1111/add.13457" class="external-link">https://doi.org/10.1111/add.13457</a>.
</div>
<div id="ref-Taskar2006" class="csl-entry">
Taskar, Varsha S, and David B Coultas. 2006. <span>“Is Idiopathic
Pulmonary Fibrosis an Environmental Disease?”</span> Journal Article.
<em>Proceedings of the American Thoracic Society</em> 3 (4): 293–98.
</div>
<div id="ref-RCP2018" class="csl-entry">
Tobacco Advisory Group of the Royal College of Physicians. 2018.
<span>“<span class="nocase">Hiding in plain sight: <span>T</span>reating
tobacco dependency in the NHS</span>.”</span> Research report.
<em>Available from:
Https://Www.rcplondon.ac.uk/Projects/Outputs/Hiding-Plain-Sight-Treating-Tobacco-Dependency-Nhs</em>.
</div>
<div id="ref-Tramacere2011" class="csl-entry">
Tramacere, Irene, Carlo La Vecchia, and Eva Negri. 2011. <span>“Brief
Report: Tobacco Smoking and Esophageal and Gastric Cardia
Adenocarcinoma: A Meta-Analysis.”</span> Journal Article.
<em>Epidemiology</em>, 344–49.
</div>
<div id="ref-Xia2017" class="csl-entry">
Xia, Jia, Lin Wang, Zhiheng Ma, Liping Zhong, Ying Wang, Yachan Gao,
Liqun He, and Xiao Su. 2017. <span>“Cigarette Smoking and Chronic Kidney
Disease in the General Population: A Systematic Review and Meta-Analysis
of Prospective Cohort Studies.”</span> Journal Article. <em>Nephrology
Dialysis Transplantation</em> 32 (3): 475–87.
</div>
<div id="ref-Ye2012" class="csl-entry">
Ye, Juan, Jinjing He, Changjun Wang, Han Wu, Xin Shi, Huina Zhang,
Jiajun Xie, and Sang Yeul Lee. 2012. <span>“Smoking and Risk of
Age-Related Cataract: A Meta-Analysis.”</span> Journal Article.
<em>Investigative Ophthalmology &amp; Visual Science</em> 53 (7):
3885–95.
</div>
<div id="ref-Zhang2016" class="csl-entry">
Zhang, Peng, Rui Wang, Zhijun Li, Yuhan Wang, Chunshi Gao, Xin Lv,
Yuanyuan Song, and Bo Li. 2016. <span>“The Risk of Smoking on Multiple
Sclerosis: A Meta-Analysis Based on 20,626 Cases from Case-Control and
Cohort Studies.”</span> Journal Article. <em>PeerJ</em> 4: e1797.
</div>
<div id="ref-Zhong2015" class="csl-entry">
Zhong, Guochao, Yi Wang, Yong Zhang, Jeff Jianfei Guo, and Yong Zhao.
2015. <span>“Smoking Is Associated with an Increased Risk of Dementia: A
Meta-Analysis of Prospective Cohort Studies with Investigation of
Potential Effect Modifiers.”</span> Journal Article. <em>PLoS One</em>
10 (3): e0118333.
</div>
<div id="ref-Zuo2017" class="csl-entry">
Zuo, Jing-Jing, Ze-Zhang Tao, Chen Chen, Zhang-Wei Hu, Ye-Xing Xu,
An-Yuan Zheng, and Yi Guo. 2017. <span>“Characteristics of Cigarette
Smoking Without Alcohol Consumption and Laryngeal Cancer: Overall and
Time-Risk Relation. A Meta-Analysis of Observational Studies.”</span>
Journal Article. <em>European Archives of Oto-Rhino-Laryngology</em> 274
(3): 1617–31.
</div>
</div>
</div>
  </div>

  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">

        <nav id="toc" data-toggle="toc"><h2 data-toc-skip>Contents</h2>
    </nav>
</div>

</div>



      <footer><div class="copyright">
  <p></p>
<p>Developed by <a href="https://www.sheffield.ac.uk/scharr/sections/heds/staff/gillespie_d" class="external-link">Duncan Gillespie</a>, Laura Webster, <a href="https://www.sheffield.ac.uk/scharr/sections/heds/staff/henney_m" class="external-link">Maddy Henney</a>, <a href="https://www.sheffield.ac.uk/scharr/sections/heds/staff/angus_c" class="external-link">Colin Angus</a>, <a href="https://www.sheffield.ac.uk/scharr/sections/heds/staff/brennan_a" class="external-link">Alan Brennan</a>.</p>
</div>

<div class="pkgdown">
  <p></p>
<p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

      </footer>
</div>

  


  

  </body>
</html>
